Literature DB >> 24138902

Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie.

M Evans1, Y Summers, P Taylor, M Harris, N Bayman, C Faivre-Finn, H Sheikh, P Burt, F Blackhall, R Califano.   

Abstract

Entities:  

Keywords:  Adenocarcinoma; EGFR activating mutations; Mutation analysis; Non-small cell lung cancer

Mesh：

Year:  2013        PMID： 24138902     DOI： 10.1016/j.lungcan.2013.09.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  1 in total

1.  Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol.

Authors:  Stuart Wright; Gavin Daker-White; William Newman; Katherine Payne
Journal:  Wellcome Open Res       Date:  2018-03-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.